Bill
S 10260
Adds CLN2, MPS IVA, MPS VI, MPS VII and Fabry diseases to the newborn screening panel for New York state
2025 Regular Session
Introduced by Kevin Parker and 1 co-sponsor
Expands New York’s newborn screening to include five lysosomal storage diseases, enabling earlier detection and timely treatment for affected infants.
REFERRED TO HEALTH